Inderbir Singh Gill, MD

Chair and Distinguished Professor of Urology

Shirley and Donald Skinner Chair in Urologic Cancer Surgery

Executive Director, USC Institute of Urology

Image of Inderbir Singh Gill, MD
Is this your profile? Click to edit

Overview

Inderbir S. Gill, MD, is Chairman & Distinguished Professor, Catherine & Joseph Aresty Department of Urology; Executive Director, USC Institute of Urology; and the Shirley & Donald Skinner Chair in Urologic Cancer Surgery at the Keck School of Medicine, University of Southern California, Los Angeles. Prior to this, he was chairman & professor, department of urology at the Cleveland Clinic, Cleveland, OH, where he was on faculty for 12 years (1997-2009).

During his 15 years in Los Angeles since 2009, USC Urology has grown in scientific stature, clinical volumes, financial productivity & philanthropy. As a result, USC Urology has progressed in U.S. News & World Report national rankings from being outside the ‘Top 50’ until 2011, to #4 in 2019, and has ranked in the ‘Top 10’ for 5 years in a row (2018-2022). In NIH Blue Ridge national rankings, USC Urology elevated from #26 in 2017 to #2 nationally (2022, 2023).

Dr Gill has published ~1,017 scientific papers with ~53,807 citations. His H-index is 123, amongst the highest in the entire field of urology https://www.scopus.com/authid/detail.uri?authorId=35415354700. He is principal investigator of a funded R-01 grant from NCI, and co-PI on other NIH grants. He is published in prestigious journals including N. Engl. J. Med., Nature, Nature Medicine, Lancet, Lancet Oncology, JAMA Surgery, etc. He has edited/co-edited 10 textbooks and has been on the editorial boards of 9 urologic journals. Dr Gill has been invited for over 450 visiting professorships, invited lectures and live surgery demonstrations world-wide. He is elected to the prestigious American Association of Genito-Urinary Surgeons (2003) and the Clinical Society of AAGUS (2009).

His various honors include: the Dr. B. C. Roy National Award for Eminent Medical Person awarded by the President of India (2005); St. Paul’s Medal by the British Urological Association (2006); honorary Fellow of the Royal College of Surgeons of England; President, 24th World Congress of Endourology & SWL (2006); USC Presidential Medallion (2013); listed in Thomson Reuters “The World’s Most Influential Scientific Minds” (2014); AUA Ramon Guiteras Lecturer (2015); AUA Chair, Global Initiatives (2015-2017); AAGUS Membership Committee (2021-2025); AUA Presidential Citation for Outstanding Contributions to Robotic Urologic Oncologic Surgery (2022); and SIU Distinguished Career Award by the Societe’ Internationale D’ Urologie (2022); and the Spence Medal from the AAGUS (2024), one of the highest honors in the field.

To date, Dr Gill has had the privilege to train over 120 urology residents and over 140 post-graduate fellows in robotic & minimally invasive urologic oncologic surgery. His fellows and faculty members are also making innovative contributions to the field, and notably, at this writing, 14 of them are current Chairs of prestigious urology departments in the U.S. and internationally.

His primary academic focus is advanced robotic urologic oncologic surgery for cancers of the kidney, bladder and prostate. His aggregate team has amongst the world’s pre-eminent robotic/laparoscopic case volumes for urologic oncologic surgery, with over 15,000+ cases in the USA. More recently, his interest has expanded to focal targeted therapy for prostate cancer. He and his team are now exploring artificial intelligence (AI) applications in urology. In 2021, under his leadership, USC Urology established the first, foundation-funded, dedicated Urology AI Center in a urology department in the nation.

On May 4, 2025, Dr Gill and Dr Nassiri performed the world’s first-in-human bladder transplant. https://www.nytimes.com/2025/05/18/health/bladder-transplant-human.html.

Awards

  • Time Magazine: “100 Most Influential People in Healthcare”, 2026
  • American Association of Urologic Surgeons: Chair, Membership Committee, 2025
  • LA Business Journal: Outstanding Collaboration of the Year, 2025
  • LA Business Journal: Best Innovation in Healthcare Award, 2024
  • American Association of Urologic Surgeons: Spence Medal, 2024
  • AUA Presidential Citation for Outstanding Contributions to Robotic Urologic Oncologic Surgery, 2022
  • Societe’ Internationale d’Urology (SIU) Distinguished Career Award, 2022
  • University of Southern California, Los Angeles, CA: Distinguished Professor of Urology, 2017
  • American Urological Association: Global Initiatives Chair, 2015
     – 2018
  • American Urology Association Annual: Ramon Guiteras Lecturer, 2015
  • Thomson Reuters: Ranked among “The World’s Most Influential Scientific Minds.”, 2014
  • University of Southern California: USC Presidential Medallion, 2013
  • Top Doctors: Pasadena Magazine, 2011
  • Urologic Society for Renal Transplantation and Renal Srugery: President, 2009
  • 24th World Congress of Endourology: President, 2006
  • British Urological Association: St. Paul’s Medal, 2006
  • Royal College of Surgeons of Edinburgh: Honorary Fellow, 2005
  • President of India for Eminent Medical Person in India: Dr. B.C. Roy National Award, 2005
  • Honorary Fellow of the Royal College of Surgeons of Edinburgh, 2005
  • Elected to the American Association of Genitourinary Surgeons, 2003
  • Cleveland Magazine: Listed in Best Doctors in Cleveland area, 1998
     – 2005
  • 1998
     -: Listed in Best Doctors in America, 1998
     – 2002
  • University of Nebraska Medical Center: Pfizer Scholars in Urology Award, 1996

Research Funding

  • Diagnosing clinically-significant prostate cancer in African American men: Systematic random versus MR-image-fusion guided biopsy
    NIH · R01CA205058 · Sep 2, 2016 – Aug 31, 2021 · Role: Principal Investigator
  • Using DNA methylation markers to improve the predictive accuracy and utility of needle biopsiesfor determining prostate cancer aggressiveness
    NIH · R21CA201865 · Jul 1, 2016 – Jun 30, 2019 · Role: Co-Principal Investigator

Publications

  • GUSL: A novel and efficient machine learning model for prostate segmentation on MRI. Comput Biol Med. 2026 Aug 15; 213:111820.. View in PubMed
  • Improving readability of layperson abstracts and summaries in oncology using task-specific large language model powered tool: results from the BRIDGE-AI 7 study. JAMIA Open. 2026 Jun; 9(3):ooag082.. View in PubMed
  • Combined bladder-kidney transplantation: first-in-human feasibility trial. Lancet. 2026 Jul 04; 408(10549):31-37.. View in PubMed
  • Intermediate clinical endpoints as surrogates for overall survival after salvage prostatectomy. BJU Int. 2026 Jun 15.. View in PubMed
  • Association between surgeon experience, level of supervision, and outcomes after hip fracture. Bone Jt Open. 2026 Jun 04; 7(6):744-752.. View in PubMed
  • Comparative Effectiveness and Cost-Effectiveness of an Artificial Intelligence Workflow for Small Renal Mass Diagnosis on Computed Tomography. Urol Pract. 2026 Jun 03; 101097.. View in PubMed
  • Partial gland ablation for radio-recurrent prostate cancer: Short-term oncological and functional outcomes. Urol Oncol. 2026 Jul; 44(7):391-399.. View in PubMed
  • Management of Femoral Head Fractures: A Systematic Review. Cureus. 2026 May; 18(5):e109127.. View in PubMed
  • Pain Perception During Transperineal and Transrectal Prostate Biopsy Under Local An-esthesia: a Prospective Analysis of a Multi-ethnic and Diverse Cohort. Int Braz J Urol. 2026 May-Jun; 52(3).. View in PubMed
  • Post pelvic binder radiograph can identify bladder injury associated with pelvic trauma: A multi-centre observational study. Injury. 2026 Jun; 57(6):113272.. View in PubMed